Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 571-577
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.571
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.571
Table 6 Lymph node metastasis by depth of invasion and histological type n (%)
| Lymph node metastasis | |||
| Presence (n = 104) | Absence (n = 1000) | Total | |
| Well differentiated | |||
| Mucosa | 0 (0.0) | 176 (17.6) | 176 (0.0) |
| Submucosa | 4 (3.8) | 56 (5.6) | 60 (6.7) |
| Moderate differentiated | |||
| Mucosa | 3 (0.0) | 165 (1.8) | 168 (1.8) |
| Submucosa | 42 (40.4) | 187 (18.7) | 229 (18.3) |
| Poorly differentiated | |||
| Mucosa | 11 (10.6) | 112 (11.2) | 123 (8.9) |
| Submucosa | 25 (24.0) | 96 (9.6) | 121 (20.7) |
| Signet ring cell | |||
| Mucosa | 10 (9.6) | 147 (14.7) | 157 (6.4) |
| Submucosa | 9 (8.7) | 61 (6.1) | 70 (12.9) |
- Citation: Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. World J Gastroenterol 2015; 21(2): 571-577
- URL: https://www.wjgnet.com/1007-9327/full/v21/i2/571.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.571